Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- MA5-13773 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- INSR alpha Monoclonal Antibody (47-9)
- Antibody type
- Monoclonal
- Antigen
- Purifed from natural sources
- Description
- MA5-13773 targets Insulin Receptor alpha in IA applications and shows reactivity with Bovine, Human, Ovine, and Porcine samples. The MA5-13773 immunogen is iM-9 lymphocytes followed by purified insulin receptor.
- Reactivity
- Human, Bovine, Porcine
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- 47-9
- Vial size
- 500 µL
- Concentration
- 0.2 mg/mL
- Storage
- 4° C
Submitted references Extracellular PBEF/NAMPT/visfatin activates pro-inflammatory signalling in human vascular smooth muscle cells through nicotinamide phosphoribosyltransferase activity.
The release of the adipocytokine visfatin is regulated by glucose and insulin.
A recombinant humanized anti-insulin-like growth factor receptor type I antibody (h7C10) enhances the antitumor activity of vinorelbine and anti-epidermal growth factor receptor therapy against human cancer xenografts.
Functional insulin receptors on human epithelial ovarian carcinoma cells: implications for IGF-II mitogenic signaling.
Increases in free, unbound insulin-like growth factor I enhance insulin responsiveness in human hepatoma G2 cells in culture.
Romacho T, Azcutia V, Vázquez-Bella M, Matesanz N, Cercas E, Nevado J, Carraro R, Rodríguez-Mañas L, Sánchez-Ferrer CF, Peiró C
Diabetologia 2009 Nov;52(11):2455-2463
Diabetologia 2009 Nov;52(11):2455-2463
The release of the adipocytokine visfatin is regulated by glucose and insulin.
Haider DG, Schaller G, Kapiotis S, Maier C, Luger A, Wolzt M
Diabetologia 2006 Aug;49(8):1909-14
Diabetologia 2006 Aug;49(8):1909-14
A recombinant humanized anti-insulin-like growth factor receptor type I antibody (h7C10) enhances the antitumor activity of vinorelbine and anti-epidermal growth factor receptor therapy against human cancer xenografts.
Goetsch L, Gonzalez A, Leger O, Beck A, Pauwels PJ, Haeuw JF, Corvaia N
International journal of cancer 2005 Jan 10;113(2):316-28
International journal of cancer 2005 Jan 10;113(2):316-28
Functional insulin receptors on human epithelial ovarian carcinoma cells: implications for IGF-II mitogenic signaling.
Kalli KR, Falowo OI, Bale LK, Zschunke MA, Roche PC, Conover CA
Endocrinology 2002 Sep;143(9):3259-67
Endocrinology 2002 Sep;143(9):3259-67
Increases in free, unbound insulin-like growth factor I enhance insulin responsiveness in human hepatoma G2 cells in culture.
Sakai K, Lowman HB, Clemmons DR
The Journal of biological chemistry 2002 Apr 19;277(16):13620-7
The Journal of biological chemistry 2002 Apr 19;277(16):13620-7
No comments: Submit comment
No validations: Submit validation data